Vista Pharma. — 360° view

Vista Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹2.42 crore and a net loss of ₹2.32 crore for the December 2025 quarter.

Vista Pharma. (BSE: VISTAPH) closed at ₹6.25 on 20 Nov 2026, down 27.5% over the past year. Its market capitalisation is ₹38 crore.

Share price
₹6.25 (20 Nov 2026)
Market cap
₹38 Cr (20 Nov 2026)
Revenue
₹2 Cr (December 2025 quarter)
Net profit
₹-2 Cr (December 2025 quarter)
ROCE
-30.3% (FY26)
ROE
-29.5% (FY26)
Book value
₹5.92 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹9.90 / ₹5.32 (20 Nov 2026)
1-year return
-27.5% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: VISTAPH

Incorporated in 1992, Vista Pharmaceuticals Ltd manufactures and sells pharmaceutical, medical and veterinary preparations

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.